Physician

John Alvin Stewart, M.D.

According to 2025 Medicare claims, John Stewart, M.D. (NPI: 1265423313) practices dermatology in the Auburn-Opelika, AL market, with the plurality of this provider's patient population coming from Lee, AL. This provider's primary affiliated billing organization is JOHN A. STEWART M.D., P.C. (NPI: 1508162231) and primary practice location at 36801-5442.

Stewart's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,021 traditional Medicare patients, billed 10,063 HCPCS/CPT codes, and received $304,637 in Medicare payments. The top billing code was 17282 (Destruction of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 1.1-2.0 cm). Part D data shows 3,387 prescription claims across 1,090 beneficiaries totaling $2,647,771 in drug costs, led by Rinvoq (Upadacitinib). Open Payments data shows 68 records totaling $1,288. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a higher plateau to a lower plateau, from $647,020 to $304,637. In contrast, Part D prescription costs have moved sharply higher in recent years, from $573,241 to $2,647,771. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$324K$647K2015 Medicare payment: $647,020 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $630,251 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $462,159 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $491,018 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $463,167 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $338,771 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $343,317 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $313,887 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $322,912 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $304,637 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20151,90833,026$647,020
20162,07733,611$630,251
20171,51124,601$462,159
20181,41018,309$491,018
20191,41814,082$463,167
20201,14711,475$338,771
20211,10711,091$343,317
20221,10511,160$313,887
20231,11811,571$322,912
20241,02110,063$304,637

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$1.3M$2.6M2015 Drug cost: $573,241 (USD; Tot_Drug_Cst)2016 Drug cost: $744,177 (USD; Tot_Drug_Cst)2017 Drug cost: $943,538 (USD; Tot_Drug_Cst)2018 Drug cost: $1,026,738 (USD; Tot_Drug_Cst)2019 Drug cost: $956,595 (USD; Tot_Drug_Cst)2020 Drug cost: $1,102,153 (USD; Tot_Drug_Cst)2021 Drug cost: $1,772,597 (USD; Tot_Drug_Cst)2022 Drug cost: $2,179,509 (USD; Tot_Drug_Cst)2023 Drug cost: $2,571,626 (USD; Tot_Drug_Cst)2024 Drug cost: $2,647,771 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20157522,166$573,241
20168202,290$744,177
20177772,242$943,538
20189342,685$1,026,738
20199902,947$956,595
20209473,057$1,102,153
20219472,977$1,772,597
20229753,077$2,179,509
20231,0293,262$2,571,626
20241,0903,387$2,647,771

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
17282Destruction of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 1.1-2.0 cm209373$101
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more318429$60
17110Destruction of skin growth, 1-14 growths421515$56
17000Destruction of precancer skin growth, 1 growth614866$28
17003Destruction of precancer skin growth, 2-14 growths5335,754$4

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
RinvoqUpadacitinib772,430$522,832
OtezlaApremilast932,790$444,269
Skyrizi PenRisankizumab-Rzaa171,260$347,623
Dupixent PenDupilumab892,450$331,105
TremfyaGuselkumab18952$247,818

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.68$1,288Janssen Biotech, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for John Alvin Stewart, M.D.?

Tedicare shows public-source Medicare data for John Alvin Stewart, M.D. (NPI 1265423313), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does John Alvin Stewart, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to John Alvin Stewart, M.D.?

John Alvin Stewart, M.D. is linked to JOHN A. STEWART M.D., P.C. (billing NPI 1508162231) in the available physician profile data.

Does John Alvin Stewart, M.D. have Open Payments data?

John Alvin Stewart, M.D. has 68 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.